---
title: "SOPHARMA AD - Notification from Ivan Badinski under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000002262"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273707461.md"
description: "SOPHARMA AD has received a notification from Ivan Badinski regarding the exercise of rights for the issuance of warrants with ISIN № BG4000002262, as per Regulation 596/2014. This notification is part of the requirements under the Act on Public Offering. Further details and additional attachments are available in the report."
datetime: "2026-01-26T13:20:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273707461.md)
  - [en](https://longbridge.com/en/news/273707461.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273707461.md)
---

# SOPHARMA AD - Notification from Ivan Badinski under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN № BG4000002262

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 32 / 2026

Date of issue: 2026-01-26

Short name of the issuer

SOPHARMA AD

Subject

Notification from Ivan Badinski under Regulation 596/2014 for exercise of rights for issue of

warrants with ISIN № BG4000002262

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Notification from Ivan Badinski under Regulation 596/2014 for exercise of rights for issue of

warrants with ISIN № BG4000002262

Annexes

File Description

Additional attachments can be found below:

20260126\_142028\_1928701908\_IBadinski\_Sopharma\_rights\_5years\_EN\_21012026.pdf

newsfile.refinitiv.com/getnewsfile/v1/story

### Related Stocks

- [AAPGV.US](https://longbridge.com/en/quote/AAPGV.US.md)

## Related News & Research

- [Former Tesla Board Member Says xAI Can 'Break In With the Big Boys' Anthropic, OpenAI and Google— but There’s a Catch](https://longbridge.com/en/news/294967014.md)
- [Big Tech's $1.2 Trillion Hyperscaler AI Bet Could Ignite the Next Semiconductor ETF Rally](https://longbridge.com/en/news/294843392.md)
- [Lockup expiry will offer the next test of investor appetite for SpaceX shares](https://longbridge.com/en/news/294905336.md)
- [The Wegovy pill's 'surprise miss' is one reason Novo Nordisk's stock is down](https://longbridge.com/en/news/294862814.md)
- [ANALYSIS-Oracle Corp goes for high-stakes ratings gamble in AI strategy](https://longbridge.com/en/news/294853731.md)